Nanoparticulate contrast agent

US10179178B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10179178-B2
Application numberUS-201314423994-A
CountryUS
Kind codeB2
Filing dateAug 27, 2013
Priority dateAug 27, 2012
Publication dateJan 15, 2019
Grant dateJan 15, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a nanoparticulate composite with two layers. One of the layers comprises one or more metals, which are a paramagnetic metal, a ferromagnetic metal, or a superparamagnetic metal. This layer also contains one or more suitable dopants. The other layer comprises one or more metals of gadolinium, manganese (II), and iron (III), in the form of an oxide or a fluoride. This layer may contain one or more lanthanide dopants. The nanoparticulate composite may be used as a contrast agent, in particular in magnetic resonance imaging.

First claim

Opening claim text (preview).

What is claimed is: 1. A nanoparticulate composite comprising a first and a second layer, wherein the first layer comprises one or more metals and one or more dopants, wherein the one or more metals comprise dysprosium (III) as a paramagnetic metal, and the one or more dopants comprise an Yb 3+ dopant; and wherein the second layer comprises gadolinium (III), being an oxide, a fluoride or a phosphate, and an Yb 3+ dopant and an Er 3+ dopant. 2. The nanoparticulate composite of claim 1 , wherein the one or more metals comprised in the first layer are an oxide or a fluoride. 3. The nanoparticulate composite of claim 1 , wherein the one or more metals comprised in the first layer comprise one or more of Dy 2 O 3 , DyF 3 , NaDyF 4 , LiDyF 4 , and KDyF 4 . 4. The nanoparticulate composite of claim 1 , wherein the second layer comprises one or more of GdF 3 , Gd 2 O 3 , GdPO 4 , LiGdF 4 , NaGdF 4 , and KGdF 4 . 5. The nanoparticulate composite of claim 1 , wherein the second layer comprises one or more further lanthanide dopants. 6. The nanoparticulate composite of claim 5 , wherein the further dopant comprised in the second layer is one or more dopants of Tm 3+ , and Ho 3+ . 7. The nanoparticulate composite of claim 1 , being a core/shell nanocrystal or a heterodimer. 8. The nanoparticulate composite of claim 7 , being a core/shell nanocrystal, wherein the first layer defines the core, and the second layer defines the shell. 9. The nanoparticulate composite of claim 8 , comprising a surfactant immobilized on the core/shell nanocrystal surface. 10. A contrast agent comprising one or more nanoparticulate composites according to claim 1 . 11. The contrast agent of claim 10 , being a T 1 -T 2 dual mode MRI contrast agent. 12. The contrast agent of claim 10 , further being configured, upon exposure to a first wavelength λ 1 of radiation, to generate a second wavelength λ 2 of radiation having a higher energy than the first wavelength λ 1 . 13. A method of performing magnetic resonance imaging or upconversion fluorescence imaging, the method comprising contacting a nanoparticulate composite of claim 1 with a sample and performing magnetic resonance imaging or upconversion fluorescence imaging on the sample. 14. The method of claim 13 , wherein the sample is an organ or a tissue of a mammal. 15. The method of claim 13 , wherein the sample is exposed to a magnetic field applied for magnetic resonance imaging.

Assignees

Inventors

Classifications

  • A61K49/183Primary

    having a (super)(para)magnetic core coated or functionalised with an inorganic material or being composed of an inorganic material entrapping the MRI-active nucleus, e.g. silica core doped with a MRI-active nucleus · CPC title

  • particles, e.g. uncoated or non-functionalised microparticles or nanoparticles · CPC title

  • Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title

  • Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations · CPC title

  • Nanotechnology for materials or surface science, e.g. nanocomposites · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10179178B2 cover?
Provided is a nanoparticulate composite with two layers. One of the layers comprises one or more metals, which are a paramagnetic metal, a ferromagnetic metal, or a superparamagnetic metal. This layer also contains one or more suitable dopants. The other layer comprises one or more metals of gadolinium, manganese (II), and iron (III), in the form of an oxide or a fluoride. This layer may contai…
Who is the assignee on this patent?
Univ Nanyang Tech, Nanyang Technology Univ
What technology area does this patent fall under?
Primary CPC classification A61K49/183. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).